contact us
Crinetics Therapeutics is on a fundraising roll, filing Friday to raise up to $86 million in its IPO. The move comes three months after the biotech picked up $63.5 million in its series B and will see its lead asset through phase 2.
Do Not Allow Advertisers to Use My Personal information
